SCHEMBL20127417

SCHEMBL20127417

c1ccc2c(c1)cc(-c1ccc(-c3c4ccccc4c(-c4cc5c6ccccc6oc5c5ccccc45)c4ccccc34)cc1)c1ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.41
AHR P35869 1/20 0.37
CYP11B1 P15538 1/20 0.36
DYRK1A Q13627 1/20 0.35
GPR84 Q9NQS5 6/20 0.35
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 3/20 0.34
RAB9A P51151 2/20 0.34
HPGD P15428 2/20 0.34
MAOB P27338 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
NPC1 O15118 1/20 0.34
ESR1 P03372 1/20 0.34
GAPDH P04406 1/20 0.34
GAA P10253 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ESR2 Q92731 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MEN1 O00255 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122468 1.00 ALOX5 (0.41) ALOX5AHRCYP11B1DYRK1AGPR84
SCHEMBL10122448 0.92 AHR (0.42) ALOX5AHRCYP11B1DYRK1AALDH1A1
SCHEMBL10122477 0.90 ALOX5 (0.42) ALOX5AHRCYP11B1DYRK1AGPR84
SCHEMBL20127425 0.90 ALOX5 (0.42) ALOX5AHRCYP11B1DYRK1AGPR84
SCHEMBL10122346 0.89 ALOX5 (0.40) ALOX5AHRCYP11B1GPR84ALDH1A1
SCHEMBL19294639 0.88 ALOX5 (0.36) ALOX5AHRCYP11B1GPR84ALDH1A1
SCHEMBL10122261 0.88 ALOX5 (0.36) ALOX5AHRGPR84ALDH1A1KDM4E
SCHEMBL10122568 0.88 ALOX5 (0.39) ALOX5AHRCYP11B1GPR84ALDH1A1
SCHEMBL20127649 0.88 ALOX5 (0.39) ALOX5AHRCYP11B1GPR84ALDH1A1
SCHEMBL15195386 0.88 ALOX5 (0.55) ALOX5AHRCYP11B1GPR84ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 ALOX5 4115/4885AHR 2558/4885CYP11B1 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.